Choosing blood thinners after a heart attack and stenting
Part of Heart & circulation clinical trials.
This study tests a tool that helps patients and doctors decide together which blood thinner treatment to use after a heart attack and stent placement, especially for people with higher bleeding risk. The tool is meant to help you understand your options and make a choice that fits your health needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are currently in the coronary care unit at the Montreal Heart Institute.
- You had a heart attack or unstable angina (acute coronary syndrome) and received a stent in your coronary artery.
- Your doctors have determined you have both high bleeding risk and high clotting risk, and both are equally important for your treatment decision.
- You are not taking blood thinners (anticoagulants) for other conditions.
- You do not have a history of stent thrombosis (clot in your stent) and do not have a blood clotting disorder.
- You are able to participate in making decisions about your care and understand spoken and written French or English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
This study tests whether tailoring blood-thinner medication based on a cheek swab can improve recovery after having a heart stent placed. Participants will be randomly assigned to one of two blood thinners, and their treatment will be adjusted based on genetic testing.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.